DreaMed Diabetes logo

DreaMed Diabetes

Empowering healthcare professionals with AI-driven diabetes care that ensures optimal treatment plans and improved patient outcomes worldwide.

est. 2014

VS
Glytec logo

Glytec

The only provider of insulin management software across the full continuum of care, from hospital to home.

75 employees · est. 2006 · Greenville, United States

Glytec is the older company (2014 vs 2006).

Side-by-Side Comparison

DreaMed Diabetes Glytec
Founded
2014 2006 older
Headquarters
Not tracked yet Greenville, United States
Employees
Not tracked yet 75
Industry
AI, Biotechnology, Enterprise Software Health Care, Health and Wellness
Funding Stage
Grant Series Unknown
Total Funding
$10.30M $41.97M
Funding Rounds
3 9
Services
Not tracked yet Not tracked yet
Target Customers
Not tracked yet Not tracked yet
Taxonomy
Artificial Intelligence, Medical Devices, Diabetes Treatment, Decision Support System, FDA Clearance, Insulin Titration, Patient-centered Care, Healthcare Professionals, Clinical Data Analysis, Remote Patient Monitoring Insulin Management Software, Diabetes Treatment, Digital Therapeutics, FDA-cleared, Clinical Decision Support, Medication Optimization, Health Information Technology, Populational Health, Digital Health, Patient Safety, Value-based Care, Medical Device, Medication Management, Healthcare Optimization
Website
dreamed-diabetes.com glytecsystems.com
DreaMed Diabetes logo

About DreaMed Diabetes

DreaMed Diabetes is a medical device and SaaS company that specializes in personalized diabetes treatment optimization solutions. Founded in 2014, the company initially gained recognition for commercializing the first artificial pancreas technology, featured in the NEJM. DreaMed Diabetes has since c...

Glytec logo

About Glytec

Glytec, The only provider of insulin management software across the full continuum of care, from hospital to home, is a healthcare-focused startup established in 2006. The company is headquartered in the United States and has recently secured a $9.00M Debt Financing investment from Silicon Valley Ba...

We will tell you when either one moves

BounceWatch watches DreaMed Diabetes and Glytec for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at DreaMed Diabetes and Glytec — by email.

Frequently Asked Questions

DreaMed Diabetes — Empowering healthcare professionals with AI-driven diabetes care that ensures optimal treatment plans and improved patient outcomes worldwide.. Glytec — The only provider of insulin management software across the full continuum of care, from hospital to home. . Both companies operate in related markets but may differ in funding stage, team size, and product focus.
DreaMed Diabetes has raised $10.30M while Glytec has raised $41.97M.
DreaMed Diabetes and Glytec operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare DreaMed Diabetes with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at DreaMed Diabetes on 11 Sep 2024, and Glytec on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy